Chronic myelogenous leukemia cost-effectiveness of therapy: Difference between revisions
No edit summary |
Mahshid |
||
Line 15: | Line 15: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Latest revision as of 21:58, 26 November 2017
Chronic myelogenous leukemia Microchapters |
Differentiating Chronic myelogenous leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Chronic myelogenous leukemia cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Chronic myelogenous leukemia cost-effectiveness of therapy |
FDA on Chronic myelogenous leukemia cost-effectiveness of therapy |
CDC on Chronic myelogenous leukemia cost-effectiveness of therapy |
Chronic myelogenous leukemia cost-effectiveness of therapy in the news |
Blogs on Chronic myelogenous leukemia cost-effectiveness of therapy |
Directions to Hospitals Treating Chronic myelogenous leukemia |
Risk calculators and risk factors for Chronic myelogenous leukemia cost-effectiveness of therapy |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
References